Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer

Published:2021-09 Issue:3 Volume:9 Page:113-118
ISSN:2287-8882
Container-title:Prostate International
language:en
Short-container-title:Prostate International

Author:

Preisser Felix^ORCID,Chun Felix. K.-.H.,Banek Severine,Wenzel Mike^ORCID,Graefen Markus,Steuber Thomas,Tilki Derya,Mandel Philipp

Publisher

Elsevier BV

Subject

Urology

Reference32 articles.

1. Time of Metastatic Disease Presentation and Volume of Disease are Prognostic for Metastatic Hormone Sensitive Prostate Cancer (mHSPC);Francini;Prostate,2018

2. Oligometastases;Hellman;J Clin Oncol [Internet],2016

3. Oligometastatic Prostate Cancer: A Shrinking Subset or an Opportunity for Cure?;Rao;Am Soc Clin Oncol Educ Book,2019

4. EAU – ESTRO – ESUR – SIOG Guidelines on Prostate Cancer;Mottet,2020

5. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer [Internet];Sweeney,2015

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of time to metastatic disease onset and extent of disease volume across metastatic hormone-sensitive and castration-resistant prostate cancer;Urologic Oncology: Seminars and Original Investigations;2024-11

2. Influence of Tumor Characteristics and Time to Metastatic Disease on Oncological Outcomes in Metachronous Metastatic Prostate Cancer Patients;Clinical Genitourinary Cancer;2024-10

3. Epidemiology, treatment patterns, and clinical outcomes in de novo oligometastatic hormone‐sensitive prostate cancer;Cancer;2024-07

4. Treatment patterns and oncological outcomes of older adults with metastatic prostate cancer in real‐world setting;Journal of the American Geriatrics Society;2024-06-26

5. Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real‐world setting of metastatic hormone‐sensitive prostate cancer patients;The Prostate;2024-05-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3